DOBEEL CO LTD has a total of 27 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Republic of Korea, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ZYCOS INC, IMAGINE PHARMA LLC and KOMIPHARM INT CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 8 | |
#2 | China | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Canada | 2 | |
#6 | Hong Kong | 2 | |
#7 | Australia | 1 | |
#8 | Brazil | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Micro-structure and nano-technology | |
#6 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Analysing materials | |
#7 | Nanostructure applications | |
#8 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Moon Hong Mo | 22 |
#2 | Yum Jung Sun | 19 |
#3 | Ahn Byung Cheol | 18 |
#4 | Lee Joo Youn | 12 |
#5 | Yoon Jae Seung | 6 |
#6 | Yoon Jaeseung | 5 |
#7 | Jo Hyun Jin | 5 |
#8 | Kim Ki Hyun | 5 |
#9 | Kim Dong Yeon | 5 |
#10 | Moon Je Young | 3 |
Publication | Filing date | Title |
---|---|---|
HK1221859A2 | An hbv vaccine and a process of preparing the same | |
CN102851313A | Hepatitis b vaccine and preparation technology thereof | |
KR100900837B1 | A powerful vaccine composition comprising lipopeptide and poly(i:c) as an adjuvant | |
KR100836745B1 | An hbv vaccine and a process of preparing the same | |
KR20070122056A | Use of colloidal gold as an adjuvant | |
CN101094651A | Spray-dried composition containing collectin family proteins or variants therof and process for preparing the same | |
BRPI0419151A | method for mass production of multimeric mannose ligand lectin | |
KR20050023046A | Method for mass production of Hepatitis B virus vaccine | |
KR20040106194A | Methods for overexpression of mannose binding lectin and formulation | |
KR20040018379A | Pre-s protein of hepatitis b virus as an adjuvant and a component ofhbv vaccine | |
KR20020029604A | exo-β-1,4-glucanase isolated from Lumbricus rubellus |